Acumen Pharmaceuticals, Inc. ABOS

Set alert

Price alert · ABOS

All alert types
0.24 USD +0.03 +14.09%

At close · Nov 2

0.22 -0.02 -8.22%

After hours · Nov 2, 7:59 PM ET

Bid
0.23 × 2
Ask
0.24 × 2
0.198 Day range 0.2668
0.198 52-week range 3.60
YTD
-88.64%
1 year
-89.15%
Open
0.2006
Prev close
0.2101
Mkt cap
17.34M
Vol
33.72M
Avg vol
1.56M
EPS
-1.55
P/E
0.00
Div yield
0.00%
More statistics
Low
0.198
High
0.2668
Forward P/E
-1.17
Beta
0.04
Short ratio
6.61
Inst. own
78.46%
Dividend
0.00
Ex-div date
Earnings
Aug 13, 2024
50-d avg
2.48
200-d avg
2.89
1y target
10.80

1m chart

Chart tools
Interval

Built from the cached one-day intraday bars.

Signals (157)
NameTimeAgo
SMA: BullishNov 2, 4:00 PM5 hours ago
SMA: BearishNov 2, 3:59 PM5 hours ago
RSI: OverboughtNov 2, 3:58 PM5 hours ago
SMA: BullishNov 2, 3:46 PM6 hours ago
SMA: BearishNov 2, 3:45 PM6 hours ago
SMA: BullishNov 2, 3:44 PM6 hours ago
MACD: Buy SignalNov 2, 3:40 PM6 hours ago
SMA: BullishNov 2, 3:38 PM6 hours ago
SMA: BearishNov 2, 3:28 PM6 hours ago
MACD: Sell SignalNov 2, 3:28 PM6 hours ago
SMA: BearishNov 2, 3:27 PM6 hours ago
SMA: BullishNov 2, 3:25 PM6 hours ago
SMA: BullishNov 2, 3:25 PM6 hours ago
MACD: Buy SignalNov 2, 3:25 PM6 hours ago
SMA: BearishNov 2, 3:24 PM6 hours ago
SMA: BearishNov 2, 3:24 PM6 hours ago
SMA: BullishNov 2, 3:22 PM6 hours ago
SMA: BullishNov 2, 3:22 PM6 hours ago
SMA: BearishNov 2, 3:21 PM6 hours ago
SMA: BullishNov 2, 3:20 PM6 hours ago
SMA: BearishNov 2, 3:16 PM6 hours ago
SMA: BullishNov 2, 3:14 PM6 hours ago
SMA: BearishNov 2, 3:13 PM6 hours ago
MACD: Sell SignalNov 2, 3:12 PM6 hours ago
RSI: OverboughtNov 2, 3:08 PM6 hours ago
SMA: BullishNov 2, 3:00 PM6 hours ago
SMA: BullishNov 2, 2:57 PM6 hours ago
SMA: BearishNov 2, 2:55 PM6 hours ago
SMA: BullishNov 2, 2:53 PM7 hours ago
MACD: Buy SignalNov 2, 2:53 PM7 hours ago
MACD: Sell SignalNov 2, 2:51 PM7 hours ago
MACD: Buy SignalNov 2, 2:50 PM7 hours ago
SMA: BearishNov 2, 2:48 PM7 hours ago
SMA: BullishNov 2, 2:47 PM7 hours ago
SMA: BearishNov 2, 2:42 PM7 hours ago
SMA: BullishNov 2, 2:41 PM7 hours ago
SMA: BearishNov 2, 2:31 PM7 hours ago
SMA: BullishNov 2, 2:30 PM7 hours ago
SMA: BearishNov 2, 2:28 PM7 hours ago
SMA: BullishNov 2, 2:27 PM7 hours ago
SMA: BullishNov 2, 2:27 PM7 hours ago
SMA: BearishNov 2, 2:18 PM7 hours ago
SMA: BearishNov 2, 2:18 PM7 hours ago
SMA: BullishNov 2, 2:17 PM7 hours ago
SMA: BullishNov 2, 2:17 PM7 hours ago
SMA: BearishNov 2, 2:13 PM7 hours ago
SMA: BearishNov 2, 2:13 PM7 hours ago
MACD: Sell SignalNov 2, 2:13 PM7 hours ago
SMA: BullishNov 2, 2:12 PM7 hours ago
SMA: BullishNov 2, 2:12 PM7 hours ago
MACD: Buy SignalNov 2, 2:12 PM7 hours ago
SMA: BearishNov 2, 2:10 PM7 hours ago
SMA: BearishNov 2, 2:10 PM7 hours ago
SMA: BullishNov 2, 2:09 PM7 hours ago
SMA: BullishNov 2, 2:09 PM7 hours ago
SMA: BearishNov 2, 2:06 PM7 hours ago
SMA: BearishNov 2, 2:04 PM7 hours ago
MACD: Sell SignalNov 2, 2:04 PM7 hours ago
MACD: Buy SignalNov 2, 1:59 PM7 hours ago
SMA: BullishNov 2, 1:58 PM7 hours ago
SMA: BullishNov 2, 1:57 PM7 hours ago
SMA: BearishNov 2, 1:56 PM7 hours ago
MACD: Sell SignalNov 2, 1:56 PM7 hours ago
SMA: BullishNov 2, 1:55 PM7 hours ago
SMA: BearishNov 2, 1:54 PM7 hours ago
SMA: BearishNov 2, 1:53 PM8 hours ago
SMA: BullishNov 2, 1:44 PM8 hours ago
SMA: BearishNov 2, 1:41 PM8 hours ago
SMA: BullishNov 2, 1:40 PM8 hours ago
MACD: Buy SignalNov 2, 1:40 PM8 hours ago
MACD: Sell SignalNov 2, 1:31 PM8 hours ago
SMA: BearishNov 2, 1:30 PM8 hours ago
SMA: BearishNov 2, 1:30 PM8 hours ago
SMA: BullishNov 2, 1:29 PM8 hours ago
SMA: BullishNov 2, 1:29 PM8 hours ago
SMA: BearishNov 2, 1:27 PM8 hours ago
SMA: BearishNov 2, 1:27 PM8 hours ago
SMA: BullishNov 2, 1:25 PM8 hours ago
SMA: BullishNov 2, 1:22 PM8 hours ago
SMA: BearishNov 2, 1:21 PM8 hours ago
SMA: BearishNov 2, 1:21 PM8 hours ago
SMA: BullishNov 2, 1:20 PM8 hours ago
SMA: BullishNov 2, 1:20 PM8 hours ago
SMA: BearishNov 2, 1:19 PM8 hours ago
SMA: BullishNov 2, 1:18 PM8 hours ago
SMA: BearishNov 2, 1:08 PM8 hours ago
SMA: BullishNov 2, 1:03 PM8 hours ago
MACD: Buy SignalNov 2, 1:03 PM8 hours ago
SMA: BearishNov 2, 1:02 PM8 hours ago
SMA: BullishNov 2, 1:01 PM8 hours ago
SMA: BearishNov 2, 12:53 PM9 hours ago
MACD: Sell SignalNov 2, 12:53 PM9 hours ago
SMA: BullishNov 2, 12:49 PM9 hours ago
SMA: BearishNov 2, 12:48 PM9 hours ago
SMA: BullishNov 2, 12:47 PM9 hours ago
MACD: Buy SignalNov 2, 12:47 PM9 hours ago
SMA: BearishNov 2, 12:41 PM9 hours ago
SMA: BullishNov 2, 12:39 PM9 hours ago
SMA: BearishNov 2, 12:38 PM9 hours ago
SMA: BullishNov 2, 12:37 PM9 hours ago
SMA: BearishNov 2, 12:28 PM9 hours ago
SMA: BullishNov 2, 12:26 PM9 hours ago
SMA: BearishNov 2, 12:25 PM9 hours ago
SMA: BullishNov 2, 12:24 PM9 hours ago
SMA: BearishNov 2, 12:20 PM9 hours ago
SMA: BearishNov 2, 12:18 PM9 hours ago
SMA: BullishNov 2, 12:17 PM9 hours ago
MACD: Sell SignalNov 2, 12:14 PM9 hours ago
SMA: BearishNov 2, 12:12 PM9 hours ago
SMA: BullishNov 2, 12:08 PM9 hours ago
SMA: BearishNov 2, 12:07 PM9 hours ago
SMA: BullishNov 2, 11:54 AM9 hours ago
MACD: Buy SignalNov 2, 11:54 AM9 hours ago
SMA: BullishNov 2, 11:52 AM10 hours ago
SMA: BearishNov 2, 11:44 AM10 hours ago
SMA: BullishNov 2, 11:42 AM10 hours ago
SMA: BearishNov 2, 11:38 AM10 hours ago
SMA: BearishNov 2, 11:38 AM10 hours ago
SMA: BullishNov 2, 11:37 AM10 hours ago
SMA: BearishNov 2, 11:34 AM10 hours ago
SMA: BullishNov 2, 11:31 AM10 hours ago
MACD: Sell SignalNov 2, 11:28 AM10 hours ago
SMA: BearishNov 2, 11:25 AM10 hours ago
RSI: OverboughtNov 2, 11:19 AM10 hours ago
SMA: BullishNov 2, 11:10 AM10 hours ago
SMA: BullishNov 2, 11:09 AM10 hours ago
SMA: BearishNov 2, 11:08 AM10 hours ago
MACD: Buy SignalNov 2, 11:05 AM10 hours ago
SMA: BullishNov 2, 11:02 AM10 hours ago
SMA: BearishNov 2, 11:01 AM10 hours ago
SMA: BullishNov 2, 11:00 AM10 hours ago
SMA: BearishNov 2, 10:53 AM11 hours ago
SMA: BullishNov 2, 10:51 AM11 hours ago
SMA: BearishNov 2, 10:50 AM11 hours ago
SMA: BullishNov 2, 10:48 AM11 hours ago
SMA: BearishNov 2, 10:41 AM11 hours ago
SMA: BearishNov 2, 10:38 AM11 hours ago
MACD: Sell SignalNov 2, 10:38 AM11 hours ago
MACD: Buy SignalNov 2, 10:30 AM11 hours ago
SMA: BullishNov 2, 10:27 AM11 hours ago
SMA: BullishNov 2, 10:27 AM11 hours ago
SMA: BearishNov 2, 10:26 AM11 hours ago
SMA: BearishNov 2, 10:26 AM11 hours ago
SMA: BullishNov 2, 10:24 AM11 hours ago
SMA: BullishNov 2, 10:24 AM11 hours ago
SMA: BearishNov 2, 10:21 AM11 hours ago
SMA: BullishNov 2, 10:20 AM11 hours ago
SMA: BearishNov 2, 10:19 AM11 hours ago
SMA: BearishNov 2, 10:17 AM11 hours ago
MACD: Sell SignalNov 2, 10:17 AM11 hours ago
MACD: Buy SignalNov 2, 10:15 AM11 hours ago
MACD: Sell SignalNov 2, 10:14 AM11 hours ago
MACD: Buy SignalNov 2, 10:09 AM11 hours ago
RSI: OverboughtNov 2, 10:09 AM11 hours ago
SMA: BullishNov 2, 10:01 AM11 hours ago
SMA: BearishNov 2, 9:58 AM11 hours ago
RSI: OverboughtNov 2, 9:50 AM12 hours ago

Key statistics

Market cap
107.54M
Enterprise value
-59.21M
Trailing P/E
0.00
Forward P/E
-1.17
PEG ratio
0.00
Price / sales
0.00
Price / book
0.50
EPS (TTM)
-1.38
Beta
0.04
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
0.00%
Revenue (TTM)
0
Revenue growth
0.00%
Free cash flow
-41.69M
Total cash
200.34M
Total debt
29.99M
Return on equity
-32.83%
Shares outstanding
60.08M
Short % of float
3.10%
50-day average
2.48
200-day average
2.89

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 10.80 +4405.6% upside
Target (low)
6.00
Target (mean)
10.80
Target (high)
15.00
Ratings (0m) 6 6 buy · 0 hold · 0 sell
  • Strong buy1
  • Buy5
  • Hold0
  • Sell0
  • Strong sell0

Next earnings

Aug 13, 2024

Expected Aug 13, 2024. Consensus EPS estimate -0.36582.

Earnings history

Financials — quick view

All financials
ABOS Revenue — quarterly 0
2022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 20262026-Q3 2026
ABOS Net income — quarterly -25.37M
2022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 20262026-Q3 2026
ABOS EPS — quarterly -0.35
2022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 20262026-Q3 2026

Earnings

ABOS recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 12, 2024Sep 1, 2024-0.36-0.50-0.14-38.89%
Aug 13, 2024Jun 1, 2024-0.28———
Aug 13, 2024Jun 1, 2024-0.28-0.34-0.06-21.43%
May 14, 2024Mar 1, 2024-0.23-0.25-0.02-8.70%
May 14, 2024Mar 1, 2024-0.23———
Mar 26, 2024Dec 1, 2023-0.29———

Upgrades / downgrades

ABOS analyst upgrades and downgrades
DateFirmActionFromTo
Nov 13, 2024HC Wainwright & Co.reitBuyBuy
Oct 3, 2024HC Wainwright & Co.reitBuyBuy
Aug 15, 2024UBSmainBuyBuy
Aug 14, 2024HC Wainwright & Co.reitBuyBuy
Jul 25, 2024Citigroupinit—Buy
May 15, 2024HC Wainwright & Co.reitBuyBuy

About Acumen Pharmaceuticals, Inc.

Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops targeted therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate sabirnetug (ACU193), a recombinant humanized immunoglobulin gamma 2 that completed Phase I clinical trial to target soluble amyloid-beta oligomers. The company has a license agreement with Lonza Sales AG to manufacture and commercialize sabirnetug; and a collaboration and license agreement with Halozyme, Inc. for the development of a subcutaneous formulation of sabirnetug. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in Charlottesville, Virginia.

Sector
Healthcare
Industry
Biotechnology
Country
United States

News

Your note

Sign in to keep a note on ABOS — it syncs with the Stock Master app.

Insider holders

ABOS insider holders
InsiderRelationLatest transactionDateShares held
BARTON RUSSELLChief Operating OfficerSaleJan 17, 202496,867
IVES JEFFREY LDirectorSaleAug 16, 20230
MEISNER DEREK MOfficerSaleJan 18, 2024108,867
O'CONNELL DANIEL JOSEPHChief Executive OfficerSaleJan 18, 2024502,485
RA CAPITAL MANAGEMENT, L.P.Director and Beneficial Owner of more than 10% of a Class of SecurityPurchaseJul 20, 20230
SIEMERS ERIC M.D.OfficerSaleJan 17, 2024117,576

Institution ownership

ABOS institution ownership
Holder% heldSharesValueReported
RA Capital Management, L.P.24.85%14,932,06326.73MSep 29, 2024
Franklin Resources, Inc.5.91%3,549,0696.35MSep 29, 2024
Sands Capital Ventures, LLC5.69%3,417,0756.12MSep 29, 2024
Blackrock Inc.3.88%2,331,5304.17MSep 29, 2024
Rock Springs Capital Management, LP3.83%2,300,0594.12MSep 29, 2024
FMR, LLC3.38%2,028,1173.63MSep 29, 2024

Fund ownership

ABOS fund ownership
Holder% heldSharesValueReported
Franklin Strategic Series-Franklin Small Cap Growth Fund2.00%1,200,3002.15MJul 30, 2024
Vanguard Total Stock Market Index Fund1.91%1,146,3162.05MSep 29, 2024
Fidelity Select Portfolios - Health Care1.90%1,140,0002.04MOct 30, 2024
iShares Russell 2000 ETF1.68%1,009,0631.81MOct 30, 2024
Franklin Strategic Series-Franklin Biotechnology Discove1.38%826,4001.48MJul 30, 2024
Fidelity Advisor Health Care Fund1.17%700,0001.25MOct 30, 2024